Company Filing History:
Years Active: 2017
Title: The Innovations of Cyril Daveu
Introduction
Cyril Daveu is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in various physiological processes.
Latest Patents
Cyril Daveu holds a patent for "Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof." This invention provides antibodies that specifically bind to Plasminogen Activator Inhibitor type-1 (PAI-1). The patent also includes pharmaceutical compositions, nucleic acids encoding anti-PAI-1 antibodies, recombinant expression vectors, and host cells for producing such antibodies or their fragments. Additionally, the invention outlines methods for using these antibodies to modulate PAI-1 activity or detect PAI-1, both in vitro and in vivo. The disclosure further details methods for creating antibodies that specifically bind to PAI-1 in its active conformational state.
Career Highlights
Cyril Daveu is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi focuses on innovative solutions in the pharmaceutical sector, contributing to advancements in medical treatments and therapies.
Collaborations
Cyril has collaborated with notable colleagues, including Alla Pritsker and Patrick Grailhe. These collaborations have enhanced the research and development efforts in the field of biotechnology.
Conclusion
Cyril Daveu's contributions to the field of biotechnology, particularly through his patent on PAI-1 antibodies, highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the pharmaceutical industry positively.